middle.news
How Safe Is Nyrada’s Xolatryp? Phase I Trial Offers Clear Answers
9:48am on Wednesday 6th of August, 2025 AEST
•
Biotechnology
Read Story
How Safe Is Nyrada’s Xolatryp? Phase I Trial Offers Clear Answers
9:48am on Wednesday 6th of August, 2025 AEST
Key Points
Phase I trial completed with 48 healthy volunteers
No dose-limiting toxicities or serious adverse events observed
Pharmacokinetics show predictable, linear dosing up to double dose
Data cleaning and database lock expected by August 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nyrada (ASX:NYR)
OPEN ARTICLE